Survey of the effect of vaginal misoprostol on post myomectomy bleeding
Phase 3
Recruiting
- Conditions
- terine myoma.Leiomyoma of uterus, unspecifiedD25.9
- Registration Number
- IRCT20220101053581N1
- Lead Sponsor
- Gorgan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 68
Inclusion Criteria
Age over 18 years
Myoma less than 8 cm in size on ultrasound
married
Exclusion Criteria
Contraindications to misoprostol
Hemorrhagic disease
Active asthma
High diastolic blood pressure
Recent use of nonsteroidal anti-inflammatory drugs
History of severe anemia; Allergies and recent blood transfusions
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduce vaginal bleeding. Timepoint: During surgery and 6 hours after surgery. Method of measurement: Based on suction and gas and long gas.
- Secondary Outcome Measures
Name Time Method Decreased transfusion of blood products. Timepoint: 6 hours after surgery. Method of measurement: Measurement of hemoglobin.